NASDAQ:INOV Inovalon Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Inovalon Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $25.17 -0.36 (-1.41 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range$24.93Now: $25.17▼$25.9850-Day Range$22.54MA: $24.66▼$25.9852-Week Range$13.39Now: $25.17▼$26.75Volume1.10 million shsAverage Volume493,417 shsMarket Capitalization$3.91 billionP/E Ratio359.57Dividend YieldN/ABeta0.76 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Inovalon Holdings, Inc., a technology company, provides cloud-based platforms empowering data-driven healthcare. It operates the Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 964,000 physicians; 519,000 clinical facilities; and approximately 264 million individuals and 42 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.Read More Beat the Market (BTM) Rank™ 1.2 Analyst's Opinion Consensus RatingInovalon has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 4 buy ratings, 3 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $22.22, Inovalon has a forecasted downside of 11.7% from its current price of $25.17.Amount of Analyst CoverageInovalon has only been the subject of 4 research reports in the past 90 days. Previous Next 2.3 Community Rank Outperform VotesInovalon has received 330 “outperform” votes. (Add your “outperform” vote.)Underperform VotesInovalon has received 379 “underperform” votes. (Add your “underperform” vote.)Community SentimentInovalon has received 53.46% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote “Outperform” if you believe INOV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldInovalon does not currently pay a dividend.Dividend GrowthInovalon does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inovalon insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $719,303.00 in company stock.Percentage Held by Insiders49.59% of the stock of Inovalon is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.44% of the stock of Inovalon is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Inovalon are expected to grow by 21.74% in the coming year, from $0.46 to $0.56 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inovalon is 359.57, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.91.Price to Earnings Ratio vs. SectorThe P/E ratio of Inovalon is 359.57, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 62.30.Price to Earnings Growth RatioInovalon has a PEG Ratio of 2.93. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioInovalon has a P/B Ratio of 5.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.2Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.15 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Data processing & preparation Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:INOV Previous Symbol CUSIPN/A CIK1619954 Webwww.inovalon.com Phone301-809-4000Debt Debt-to-Equity Ratio1.35 Current Ratio1.88 Quick Ratio1.88Price-To-Earnings Trailing P/E Ratio359.57 Forward P/E Ratio54.72 P/E Growth2.93 Sales & Book Value Annual Sales$642.41 million Price / Sales6.09 Cash Flow$1.18 per share Price / Cash Flow21.34 Book Value$4.44 per share Price / Book5.67Profitability EPS (Most Recent Fiscal Year)$0.41 Net Income$7.78 million Net Margins1.75% Return on Equity9.09% Return on Assets3.17%Miscellaneous Employees2,662 Outstanding Shares155,351,000Market Cap$3.91 billion Next Earnings Date11/4/2020 (Estimated) OptionableOptionable $25.17 -0.36 (-1.41 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive INOV News and Ratings via Email Sign-up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter. Inovalon (NASDAQ:INOV) Frequently Asked Questions How has Inovalon's stock been impacted by Coronavirus (COVID-19)? Inovalon's stock was trading at $17.36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, INOV stock has increased by 45.0% and is now trading at $25.17. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Inovalon? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Inovalon. When is Inovalon's next earnings date? Inovalon is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020. View our earnings forecast for Inovalon. How were Inovalon's earnings last quarter? Inovalon Holdings Inc (NASDAQ:INOV) posted its quarterly earnings results on Wednesday, July, 29th. The technology company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of $0.11 by $0.04. The technology company had revenue of $162.20 million for the quarter, compared to analysts' expectations of $159.46 million. Inovalon had a net margin of 1.75% and a return on equity of 9.09%. The firm's quarterly revenue was up 3.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.13 earnings per share. View Inovalon's earnings history. What guidance has Inovalon issued on next quarter's earnings? Inovalon issued an update on its FY20 earnings guidance on Wednesday, July, 29th. The company provided EPS guidance of $0.57-0.61 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.56. The company issued revenue guidance of $675-698 million, compared to the consensus revenue estimate of $680.69 million. What price target have analysts set for INOV? 8 equities research analysts have issued 12-month price objectives for Inovalon's shares. Their forecasts range from $12.00 to $29.00. On average, they expect Inovalon's stock price to reach $22.22 in the next year. This suggests that the stock has a possible downside of 11.7%. View analysts' price targets for Inovalon. Who are some of Inovalon's key competitors? Some companies that are related to Inovalon include StoneCo (STNE), Bilibili (BILI), PagSeguro Digital (PAGS), Autohome (ATHM), Clarivate Analytics (CCC), Zendesk (ZEN), Pegasystems (PEGA), Zynga (ZNGA), Five9 (FIVN), Globant (GLOB), YY (YY), Proofpoint (PFPT), Corelogic (CLGX), DXC Technology (DXC) and Change Healthcare (CHNG). View all competitors. What other stocks do shareholders of Inovalon own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), NVIDIA (NVDA), Paypal (PYPL), Square (SQ), Taiwan Semiconductor Mfg. (TSM), Digital Turbine (APPS), DexCom (DXCM) and Enphase Energy (ENPH). Who are Inovalon's key executives? Inovalon's management team includes the following people: Keith R. Dunleavy, CEO & Chairman (Age 50)Mr. Robert A. Wychulis, Pres (Age 64)Mr. John Michael Burgin, Chief Product Officer (Age 45)Mr. Jonathan R. Boldt, Chief Financial Officer (Age 34)Mr. Jason B. Capitel, Chief Operating Officer (Age 47) When did Inovalon IPO? (INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers. What is Inovalon's stock symbol? Inovalon trades on the NASDAQ under the ticker symbol "INOV." Who are Inovalon's major shareholders? Inovalon's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (4.74%), Black Creek Investment Management Inc. (2.89%), FMR LLC (1.73%), Neuberger Berman Group LLC (1.64%), Bernzott Capital Advisors (1.04%) and Riverbridge Partners LLC (0.97%). Company insiders that own Inovalon stock include Jason Capitel, Jonathan R Boldt, Keith R Dunleavy and Robert A Wychulis. View institutional ownership trends for Inovalon. Which major investors are selling Inovalon stock? INOV stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Marshall Wace LLP, Black Creek Investment Management Inc., Cowen Prime Services LLC, Neuberger Berman Group LLC, Avalon Investment & Advisory, Riverbridge Partners LLC, and Natixis Advisors L.P.. Company insiders that have sold Inovalon company stock in the last year include Jason Capitel, Jonathan R Boldt, and Robert A Wychulis. View insider buying and selling activity for Inovalon. Which major investors are buying Inovalon stock? INOV stock was purchased by a variety of institutional investors in the last quarter, including Redwood Investments LLC, Nordea Investment Management AB, Goldman Sachs Group Inc., Bernzott Capital Advisors, Vanguard Group Inc., Prudential Financial Inc., GAM Holding AG, and Nuveen Asset Management LLC. Company insiders that have bought Inovalon stock in the last two years include Jason Capitel, and Keith R Dunleavy. View insider buying and selling activity for Inovalon. How do I buy shares of Inovalon? Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Inovalon's stock price today? One share of INOV stock can currently be purchased for approximately $25.17. How big of a company is Inovalon? Inovalon has a market capitalization of $3.91 billion and generates $642.41 million in revenue each year. The technology company earns $7.78 million in net income (profit) each year or $0.41 on an earnings per share basis. Inovalon employs 2,662 workers across the globe. What is Inovalon's official website? The official website for Inovalon is www.inovalon.com. How can I contact Inovalon? Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected] This page was last updated on 9/19/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
